Patterns and Predictors of Use of Anticoagulants for the Treatment of Venous Thromboembolism Following Approval of Rivaroxaban

Conclusion:
Several months following its availability, rivaroxaban was rarely prescribed for acute VTE disease. It also appears to be prescribed in different patient populations than VKA.

Source: Clinical and Applied Thrombosis/Hemostasis - October 6, 2016 Category: Hematology Authors: Dault, R., Vanasse, A., Blais, L., Perreault, S., Farand, P., Le Templier, G., Beauchesne, M.-F. Tags: Original Articles Source Type: research